Pnc Financial Services Group, Inc. Immunome Inc. Transaction History

Pnc Financial Services Group, Inc.

  • $162 Billion
  • Q3 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Immunome Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 551 shares of IMNM stock, worth $9,444. This represents 0.0% of its overall portfolio holdings.

Number of Shares
551
Previous 353 56.09%
Holding current value
$9,444
Previous $3,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$8.4 - $11.59 $1,663 - $2,294
198 Added 56.09%
551 $6,000
Q3 2024

Nov 08, 2024
BUY
$11.7 - $16.51 $4,130 - $5,828
353 New
353 $5,000

Others Institutions Holding IMNM

# of Institutions
167
Shares Held
71.7M
Call Options Held
325K
Put Options Held
4.31M
View Full List

About Immunome Inc.

IMNM Quotes by TradingView
  • Ticker IMNM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,127,400
  • Market Cap $208M
  • Description
  • Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...
More about IMNM
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email